Biotage AB (publ)

Biotage AB (publ)

BITGF

$15.01

Updated: 24/09/2026, 11:42:34

Market Cap
$1.20B
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Country
SE

No historical data available

Company Profile

Biotage AB (publ) specializes in advanced separation science solutions for organic and analytical chemistry, biomolecular research, and industrial-scale applications. The company's comprehensive offerings include products for organic and peptide synthesis, flash chromatography, evaporation, and sample work-up, alongside a variety of flash systems, accessories, and chromatographic cartridges (normal, reversed, and specialized phases). Additional solutions encompass plasmid purification, metal scavengers, chemical reagents, and essential spare parts. Biotage also provides extensive sample preparation systems and consumables, catering to diverse fields such as clinical, bioanalytical, forensic, toxicology, human and animal doping control, environmental analysis, and food and agriculture. Furthermore, it delivers specialized protein purification solutions, including systems for antibody and tagged protein purification, automation, custom packing services, and a range of PhyTip columns utilizing ion exchange, reversed phase, normal phase, and gel filtration technologies. Its clientele spans pharmaceutical and biotechnology companies, contract research and manufacturing organizations, government bodies, academic institutions, and various clinical and forensic laboratories. Established in 1969 and headquartered in Uppsala, Sweden, Biotage maintains a global presence, operating in 70 countries across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region.

USD
OTC
CEO: Frederic Vanderhaegen
Employees: 622
https://www.biotage.com
Asset Summaries
Latest generated summaries for BITGF

No summaries found.

Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for BITGF.
Share price
$15.01
Market cap
$1.20B
Exchange
OTC
Currency
USD
CEO
Frederic Vanderhaegen
Employees
622
IPO date
18/02/2010
Beta
0.853
Last dividend
$0.00
Day range
$14.87 – $15.01
52-week range
$11.50 – $18.52
1-day performance
0.00%
1-year performance
30.56%
Current drawdown (1Y)
-18.93%
CIK
N/A
CUSIP
N/A
ISIN
SE0000454746
Created
07/12/2025, 03:00:46
Last update
24/09/2026, 11:42:34

Track Biotage AB (publ) with an AI analyst

See which prediction-market events move BITGF, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.

Latest Database News
News linked to BITGF from your Railway `news_articles` table.

No news found for this symbol.